These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Indian company seeks US approval for generic AIDS drugs. Nature; 2004 Aug; 430(7001):716. PubMed ID: 15306779 [No Abstract] [Full Text] [Related]
3. Drug marketing exclusivity under United States and European Union law. Junod V Food Drug Law J; 2004; 59(4):479-518. PubMed ID: 15875347 [No Abstract] [Full Text] [Related]
4. Potential pathways for abbreviated approval of generic biologics under existing law and proposed reforms to the law. Dinh TQ Food Drug Law J; 2007; 62(1):77-137. PubMed ID: 17444027 [No Abstract] [Full Text] [Related]
6. Old drugs, new uses: solving a Hatch-Waxman patent predicament. McPhie DC Food Drug Law J; 2004; 59(1):155-68. PubMed ID: 15190929 [No Abstract] [Full Text] [Related]
7. A precarious balancing act--the role of the FDA as protector of public health and industry wealth. McCabe AR Suffolk Univ Law Rev; 2003; 36(3):787-819. PubMed ID: 16493844 [No Abstract] [Full Text] [Related]
8. SuperGenerics: a better alternative for biogenerics. Charles SA Drug Discov Today; 2005 Apr; 10(8):533-5. PubMed ID: 15837591 [No Abstract] [Full Text] [Related]
11. The Drug Price Competition and Patent Term Restoration Act of 1984: fine-tuning the balance between the interests of pioneer and generic drug manufacturers. Soehnge H Food Drug Law J; 2003; 58(1):51-80. PubMed ID: 12739584 [No Abstract] [Full Text] [Related]
12. The United States Food and Drugs Administration approves a generic enoxaparin. Ofosu FA Clin Appl Thromb Hemost; 2011 Feb; 17(1):5-8. PubMed ID: 21159709 [TBL] [Abstract][Full Text] [Related]
14. Path to approval proves rocky for copycat biodrugs. Wadman M Nature; 2005 Nov; 438(7065):154-5. PubMed ID: 16281004 [No Abstract] [Full Text] [Related]
15. Generic drug approval: a US perspective. Nagori BP; Mathur V; Garg S Curr Med Res Opin; 2011 Mar; 27(3):541-5. PubMed ID: 21219120 [TBL] [Abstract][Full Text] [Related]
16. The problem of new uses. Eisenberg RS Yale J Health Policy Law Ethics; 2005; 5(2):717-39. PubMed ID: 16052897 [No Abstract] [Full Text] [Related]
17. Branded drug reformulation: the next brand vs. generic antitrust battleground. Amoresano GV Food Drug Law J; 2007; 62(1):249-56. PubMed ID: 17444032 [No Abstract] [Full Text] [Related]
18. Maine law requires drug companies to provide clinical trial data. Appell D J Natl Cancer Inst; 2005 Sep; 97(17):1246. PubMed ID: 16145043 [No Abstract] [Full Text] [Related]
19. FDA notifications. Tentative approval for generic stavudine, oral solution. AIDS Alert; 2007 Dec; 22(12):142. PubMed ID: 18415959 [No Abstract] [Full Text] [Related]
20. FDA notifications. Tentative approval for generic nevirapine tablets. AIDS Alert; 2007 Oct; 22(10):118-9. PubMed ID: 18418905 [No Abstract] [Full Text] [Related] [Next] [New Search]